psalexa
logo

Infection Surveillance Solutions Market

Global Infection Surveillance Solutions Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS11114
Available Format:
Category : Healthcare IT

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Product

1.3.2. Market Segmentation by End User

1.3.3. Market Segmentation by Region

1.3.4. Analysis Period

1.3.5. Market Data Reporting Unit

1.3.5.1. Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Product

4.1.1.1. Software

4.1.1.1.1. On-premise software

4.1.1.1.2. Cloud-based software

4.1.1.2. Services

4.1.1.2.1. Product support & maintenance services

4.1.1.2.2. Training & consultancy services

4.1.1.2.3. Implementation services

4.1.2. Overview by End User

4.1.2.1. Hospitals

4.1.2.1.1. Large hospitals

4.1.2.1.2. Medium-sized hospitals

4.1.2.1.3. Small hospitals

4.1.2.2. Long-term care facilities

4.1.2.2.1. Nursing homes

4.1.2.2.2. Skilled nursing facilities

4.1.2.2.3. Assisted living facilities

4.1.2.3. Others

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers

4.2.2.1. Impact analysis of drivers on market forecast

4.2.3. Restraints

4.2.3.1. Impact analysis of drivers on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Product

5.1. Software

5.1.1. On-Premise Software

5.1.2. Web-Based Software

5.2. Services

5.2.1. Product Support & Maintenance Services

5.2.2. Training & Consulting Services

5.2.3. Implementation Services

Chapter 6. Market Size and Forecast by End User

6.1. Hospitals

6.1.1. Large Hospitals

6.1.2. Medium-Sized Hospitals

6.1.3. Small Hospitals

6.2. Long-Term Care Facilities

6.2.1. Nursing Homes

6.2.2. Skilled Nursing Facilities

6.2.3. Assisted Living Facilities

6.3. Others

Chapter 7. Market Size and Forecast by Region

7.1. North America Infection Surveillance Solutions Market

7.1.1. By Product

7.1.2. By End User

7.1.3. By Country – The U.S. and Canada

7.2. Europe Infection Surveillance Solutions Market

7.2.1. By Product

7.2.2. By End User

7.2.3. By Country – The U.K., Spain, Germany, Italy, France, Russia and Rest of Europe

7.3. Asia-Pacific Infection Surveillance Solutions Market

7.3.1. By Product

7.3.2. By End User

7.3.3. By Country – China, Japan, India, Australia, and Rest of Asia-Pacific

7.4. Latin America Infection Surveillance Solutions Market

7.4.1. By Product

7.4.2. By End User

7.4.3. By Country – Brazil, Mexico and Rest of Latin America

7.5. Middle East & Africa Infection Surveillance Solutions Market

7.5.1. By Product

7.5.2. End User

7.5.3. By Country – South Africa and Rest of Middle East & Africa

Chapter 8. Competitive Landscape

8.1. Competitive Analysis of Key Players

8.2. Global Strategic Developments

Chapter 9. Company Profiles

9.1. Becton, Dickinson and Company

9.1.1. Business Overview

9.1.2. Product and Service Offerings

9.1.3. Key Financial Summary

9.1.4. Strategic Growth Plan

9.2. Premier Inc.

9.2.1. Business Overview

9.2.2. Product and Service Offerings

9.2.3. Key Financial Summary

9.2.4. Strategic Growth Plan

9.3. Wolters Kluwer N.V.

9.3.1. Business Overview

9.3.2. Product and Service Offerings

9.3.3. Key Financial Summary

9.3.4. Strategic Growth Plan

9.4. Baxter International Inc.

9.4.1. Business Overview

9.4.2. Product and Service Offerings

9.4.3. Key Financial Summary

9.4.4. Strategic Growth Plan

9.5. Gojo Industries, Inc.

9.5.1. Business Overview

9.5.2. Product and Service Offerings

9.5.3. Key Financial Summary

9.5.4. Strategic Growth Plan

9.6. RL Solutions

9.6.1. Business Overview

9.6.2. Product and Service Offerings

9.6.3. Key Financial Summary

9.6.4. Strategic Growth Plan

9.7. Truven Health Analytics (An IBM Company)

9.7.1. Business Overview

9.7.2. Product and Service Offerings

9.7.3. Key Financial Summary

9.7.4. Strategic Growth Plan

9.8. DEB Group Ltd.

9.8.1. Business Overview

9.8.2. Product and Service Offerings

9.8.3. Key Financial Summary

9.8.4. Strategic Growth Plan

9.9. Hygreen, Inc.

9.9.1. Business Overview

9.9.2. Product and Service Offerings

9.9.3. Key Financial Summary

9.9.4. Strategic Growth Plan

9.10. Atlas Medical Software

9.10.1. Business Overview

9.10.2. Product and Service Offerings

9.10.3. Key Financial Summary

9.10.4. Strategic Growth Plan

*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 10. Appendix

10.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry